<DOC>
	<DOCNO>NCT00989066</DOCNO>
	<brief_summary>To evaluate performance long-term clinical outcome Xience V everolimus-eluting coronary stent system ( EECSS ) treatment minimally selective , high risk patient real-world clinical practice .</brief_summary>
	<brief_title>Brazil Xience V Everolimus-Eluting Coronary Stent System `` Real-World '' Outcomes Registry</brief_title>
	<detailed_description>Prospective , multicenter , non-randomized , post-marketing web-based registry.Patients comer assign percutaneous coronary intervention ( PCI ) present least one angiographically document coronary artery lesion suitable percutaneous treatment implantation Xience V EECSS include Registry .</detailed_description>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Patients &gt; 18 year age ; clinical indication elective emergency PCI stent implantation least one angiographically document coronary artery lesion ; agreement undergo ALL study protocol followup Diseased coronary vessel ( ) presence least one obstruction &gt; 50 % diameter stenosis visual estimation major epicardial vessel major branch ( â‰¥2.50mm ) , anatomy suitable percutaneous treatment implantation Xience V EECSS Known illness life expectancy &lt; 24 month ; impossibility comply protocol followup Coronary anatomy unsuitable percutaneous treatment implantation Xience V EECSS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Xience V</keyword>
	<keyword>stent</keyword>
	<keyword>coronary disease</keyword>
</DOC>